May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Long-Term Results of Photodynamic Therapy for Choroidal Neovascularization in Young Patients
Author Affiliations & Notes
  • K. Fujisato
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • A. Otani
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • M. Sasahara
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • Y. Yodoi
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • H. Aikawa
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • H. Tamura
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • A. Tsujikawa
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • N. Yoshimura
    Ophthalmology, Kyoto Univ Grad Sch of Med, Kyoto, Japan
  • Footnotes
    Commercial Relationships  K. Fujisato, None; A. Otani, None; M. Sasahara, None; Y. Yodoi, None; H. Aikawa, None; H. Tamura, None; A. Tsujikawa, None; N. Yoshimura, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2676. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Fujisato, A. Otani, M. Sasahara, Y. Yodoi, H. Aikawa, H. Tamura, A. Tsujikawa, N. Yoshimura; Long-Term Results of Photodynamic Therapy for Choroidal Neovascularization in Young Patients. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2676. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the safety and efficacy of photodynamic therapy (PDT) with verteporfin in treating choroidal neovascularization (CNV) in young Japanese patients.

Methods: : We performed a retrospective analysis of 10 eyes of 10 patients (all female) aged 50 years or younger with the diagnosis of CNV. The average age was 35.0±10.7 (ranged 19 to 47 year old) years. Eight eyes were idiopathic and 2 were myopic origin. Five eyes were treated by PDT (Mean 2.6 times). The visual, clinical, angiographic responses and complications were investigated. Mean follow-up periods were 33.2±13.5 (ranged 22 to 57 months) months.

Results: : Final best-corrected visual acuity (BCVA) ranged 0.08 to 1.2 and seven eyes (70%) retained final BCVA of 0.5 or more. In changes of BCVA, 40% (2 eyes) were improved, 40% (2 eyes) showed no change, and 20% (1 eye) worsened in both PDT-treated and non-treated groups. The initial mean BCVA was significantly worse in PDT treated group than non-PDT treated group (0.56 vs. 0.21, P=0.029). The mean CNV size was significantly larger in PDT treated group (1716 µm vs. 782 µm, P=0.015). In non-PDT treated group, 3 eyes (60%) had juxtafoveal CNV and 1 eye (20%) had extrafoveal CNV. Only one eye developed subfoveal CNV during follow-up periods. In contrast, all five eyes in PDT-treated group involved subfoveal region. No serious local or systemic complications were encountered.

Conclusions: : PDT seems to be a good treatment strategy in achieving a stable or improved vision for young CNV patients, even if they had worse visual acuity or large CNV in their initial visits. Further prospective studies are expected.

Keywords: photodynamic therapy • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×